PATENT CLAIM ANALYSIS

Application Number: 16178865
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "487000"]

Abstract:
The present invention provides a simple and improved dosage form that is capable of providing a controlled release of GABA B  receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABA B  receptor agonist.

Claim (Index 13):
The dosage form of  claim 11 , wherein the semipermeable membrane comprises plasticizer and about 80% wt to less than 100% wt of cellulose ester based upon the final weight of the membrane.

Metadata:
- Claim Count in Document: 101.0
- Percentile: 98.0
- Lexical Diversity: 1.47222
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15673781', '15680434', '15048743', '15919422', '15919436']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8439859041785519
- 35 USC 102 Novelty (BERT): 0.6077377649726953
- Combined Prediction Score: 0.8203610902579663
- Mean Citation Score: 562.2168720000002
- Max Citation Score: 573.3431
- Similarity Product: 457.75045843335386

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test